Evidence map›Paper›PMID 31458673›Full record

ArticleACS omega2018

Use of the Multilayer Fragment Molecular Orbital Method to Predict the Rank Order of Protein-Ligand Binding Affinities: A Case Study Using Tankyrase 2 Inhibitors.

Noriaki Okimoto, Takao Otsuka, Yoshinori Hirano, Makoto Taiji

Abstract read
In one paragraph

Article in ACS omega, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Noriaki OkimotoLaboratory for Computational Molecular Design, Computational Biology Research Core, Quantitative Biology Center (QBiC), RIKEN, QBiC Building B, 6-2-4 Furuedai, Suita, Osaka 565-0874, Japan.
Takao OtsukaLaboratory for Computational Molecular Design, Computational Biology Research Core, Quantitative Biology Center (QBiC), RIKEN, QBiC Building B, 6-2-4 Furuedai, Suita, Osaka 565-0874, Japan.
Yoshinori HiranoLaboratory for Computational Molecular Design, Computational Biology Research Core, Quantitative Biology Center (QBiC), RIKEN, QBiC Building B, 6-2-4 Furuedai, Suita, Osaka 565-0874, Japan.
Makoto TaijiLaboratory for Computational Molecular Design, Computational Biology Research Core, Quantitative Biology Center (QBiC), RIKEN, QBiC Building B, 6-2-4 Furuedai, Suita, Osaka 565-0874, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In computational drug discovery, ranking a series of compound analogues in the order that is consistent with the experimental binding affinities remains a challenge. Many of the computational methods available for evaluating binding affinities have adopted molecular mechanics (MM)-based force fields, although they cannot completely describe protein-ligand interactions. By contrast, quantum mechanics (QM) calculations play an important role in understanding the protein-ligand interactions; however, their huge computational costs hinder their application in drug discovery. In this study, we have evaluated the ability to rank the binding affinities of tankyrase 2 ligands by combining both MM and QM calculations. Our computational approach uses the protein-ligand binding energies obtained from a cost-effective multilayer fragment molecular orbital (MFMO) method combined with the solvation energy obtained from the MM-Poisson-Boltzmann/surface area (MM-PB/SA) method to predict the binding affinity. This approach enabled us to rank tankyrase 2 inhibitor analogues, outperforming several MM-based methods, including rescoring by molecular docking and the MM-PB/SA method alone. Our results show that this computational approach using the MFMO method is a promising tool for predicting the rank order of the binding affinities of inhibitor analogues.

Identifiers

PMID31458673
PMCPMC6641631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.